» Articles » PMID: 36503451

K-Related Neurological Disorders: Phenotypic Spectrum and Therapeutic Indications

Overview
Date 2022 Dec 12
PMID 36503451
Authors
Affiliations
Soon will be listed here.
Abstract

Although potassium channelopathies have been linked to a wide range of neurological conditions, the underlying pathogenic mechanism is not always clear, and a systematic summary of clinical manifestation is absent. Several neurological disorders have been associated with alterations of calcium-activated potassium channels (K channels), such as loss- or gain-of-function mutations, post-transcriptional modification, etc. Here, we outlined the current understanding of the molecular and cellular properties of three subtypes of K channels, including big conductance K channels (BK), small conductance K channels (SK), and the intermediate conductance K channels (IK). Next, we comprehensively reviewed the loss- or gain-of-function mutations of each K channel and described the corresponding mutation sites in specific diseases to broaden the phenotypic-genotypic spectrum of K-related neurological disorders. Moreover, we reviewed the current pharmaceutical strategies targeting K channels in K-related neurological disorders to provide new directions for drug discovery in anti-seizure medication.

Citing Articles

Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121.

Kolski-Andreaco A, Taiclet S, Myerburg M, Sembrat J, Bridges R, Straub A J Clin Invest. 2024; 134(16.

PMID: 38954478 PMC: 11324306. DOI: 10.1172/JCI176328.

References
1.
Stackman R, Hammond R, Linardatos E, Gerlach A, Maylie J, Adelman J . Small conductance Ca2+-activated K+ channels modulate synaptic plasticity and memory encoding. J Neurosci. 2002; 22(23):10163-71. PMC: 6758766. View

2.
Lakshmikanthcharan S, Hisham M, Chaitanya Juluri S, Nandakumar S . Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy. Indian J Crit Care Med. 2018; 22(9):680-682. PMC: 6161577. DOI: 10.4103/ijccm.IJCCM_250_18. View

3.
Garcia-Junco-Clemente P, Cantero G, Gomez-Sanchez L, Linares-Clemente P, Martinez-Lopez J, Lujan R . Cysteine string protein-alpha prevents activity-dependent degeneration in GABAergic synapses. J Neurosci. 2010; 30(21):7377-91. PMC: 6632397. DOI: 10.1523/JNEUROSCI.0924-10.2010. View

4.
Nappi P, Miceli F, Soldovieri M, Ambrosino P, Barrese V, Taglialatela M . Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction. Pflugers Arch. 2020; 472(7):881-898. DOI: 10.1007/s00424-020-02404-2. View

5.
Shakkottai V, Chou C, Oddo S, Sailer C, Knaus H, Gutman G . Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. J Clin Invest. 2004; 113(4):582-90. PMC: 338266. DOI: 10.1172/JCI20216. View